Andrew Briggs is Professor of Health Economics at the London School of Hygiene & Tropical Medicine, and previously held the William R Lindsay Chair in Health Economics at the University of Glasgow. Following a sabbatical at Memorial Sloan Kettering Cancer Center, New York in 2016/17, he remains a Visiting Investigator, collaborating with Dr Peter Bach on value frameworks for oncology medications.
His main methodological focus of research has been health economic evaluation, particularly statistical methods for cost-effectiveness analysis. This includes statistical methods for estimation of parameters for cost-effectiveness models as well as statistical analysis of cost-effectiveness alongside clinical trials. He has a more general interest in epidemiological methods, in particular the use of prognostic scoring methods for predicting health outcomes and the relationship with heterogeneity in cost-effectiveness analysis.
He has co-authored two textbooks, one published by OUP entitled Decision Modelling for Health Economic Evaluation, and the other published by Wiley entitled Statistical Methods for Cost-Effectiveness Analysis.
SPEAKER: EXPLORING VALUE: NOVEL ELEMENTS FOR BREAKTHROUGH TREATMENTS